Ridogrel

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameRidogrel
Drug Alias NameRidogrelum利多格瑞利多瑞尔利多格雷Ibidel +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThromboxane A2 synthase inhibitorsThromboxane A2 receptor antagonists
TargetsThromboxane A2 synthaseThromboxane A2 receptor
Therapy Area/IndicationsColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson Innovative Medicine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohnson & Johnson Innovative Medicine
Active IndicationsN/A
Inactive IndicationsColitis, Ulcerative

Other Information

ATC CodeN/A
Related LinksDrugBankKEGG